Scientific Report 2012. Madrid. CNIC; 2013
One of the CNIC’s most important goals in these times of recession is to secure and maintain long term financial support. In June 2012, the Ministry for Economic Affairs and the consortium of private companies in the Pro-CNIC Foundation renewed their commitment to the CNIC. This unique public-private joint initiative is allowing our center to maintain the pioneering drive that resulted in our accreditation as a Severo Ochoa’s Center of Excellence in 2011, one of only eight institutes to receive this award in its inaugural year. During 2012 the CNIC has been intensively seeking competitive external research funding, presenting more than 34 applications to the 7th European Union Framework Programme and 17 applications to other international agencies (NIH, Leducq Foundation, etc.). The Center also secured financing from the Spanish Company Fina Biotech to study genetic risk markers of restenosis after coronary stent implantation. The continuing support for the CNIC from the public and private sectors is based on the strength of our programs in basic and translational research and our innovative training programs aimed at identifying and supporting talent and cementing long term collaboration between basic researchers and clinicians. [...]
